December 21, 2023
Accurius Therapeutics to present at upcoming Biotech Showcase™
Oncolytic Immunotherapy developer to preview novel oncolytic virus targeted at lung cancer
Oncolytic Immunotherapy developer to preview novel oncolytic virus targeted at lung cancer
December 20, 2023
Accurius Therapeutics awarded prestigious NIH FastTrack grant
Funds will be used to further develop novel oncolytic virus targeted at lung cancer
Funds will be used to further develop novel oncolytic virus targeted at lung cancer